HPC
GILD icon

HM Payson & Co’s Gilead Sciences GILD Stock Holding History

HM Payson & Co’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$892K Sell
7,060
-376
-5% -$49.5K 0.01% 238
2026
Q1 		$1.04M Buy
7,436
+376
+5% +$52.7K 0.02% 223
2025
Q4 		$867K Hold
7,060
– – 0.01% 237
2025
Q3 		$784K Buy
7,060
+1,003
+17% +$114K 0.01% 241
2025
Q2 		$672K Sell
6,057
-1
-0% -$106 0.01% 248
2025
Q1 		$679K Buy
6,058
+527
+10% +$54.4K 0.01% 250
2024
Q4 		$511K Sell
5,531
-18
-0.3% -$1.62K 0.01% 276
2024
Q3 		$465K Sell
5,549
-1,677
-23% -$128K 0.01% 296
2024
Q2 		$496K Buy
7,226
+915
+14% +$61.1K 0.01% 273
2024
Q1 		$462K Sell
6,311
-101
-2% -$7.77K 0.01% 292
2023
Q4 		$519K Sell
6,412
-769
-11% -$59.8K 0.01% 269
2023
Q3 		$538K Buy
7,181
+200
+3% +$15.4K 0.01% 253
2023
Q2 		$538K Hold
6,981
– – 0.01% 250
2023
Q1 		$579K Buy
6,981
+500
+8% +$41.4K 0.01% 235
2022
Q4 		$556K Sell
6,481
-940
-13% -$74.4K 0.01% 236
2022
Q3 		$458K Buy
7,421
+900
+14% +$56.8K 0.01% 254
2022
Q2 		$403K Sell
6,521
-326
-5% -$20.2K 0.01% 270
2022
Q1 		$407K Sell
6,847
-1,024
-13% -$65.5K 0.01% 295
2021
Q4 		$571K Sell
7,871
-1,310
-14% -$90.2K 0.01% 267
2021
Q3 		$641K Hold
9,181
– – 0.02% 245
2021
Q2 		$632K Sell
9,181
-35
-0.4% -$2.34K 0.02% 247
2021
Q1 		$596K Sell
9,216
-115
-1% -$7.42K 0.02% 254
2020
Q4 		$544K Sell
9,331
-454
-5% -$27.4K 0.02% 260
2020
Q3 		$618K Buy
9,785
+454
+5% +$31.5K 0.02% 236
2020
Q2 		$718K Sell
9,331
-350
-4% -$26.8K 0.02% 211
2020
Q1 		$724K Sell
9,681
-1,450
-13% -$100K 0.03% 190
2019
Q4 		$723K Sell
11,131
-184
-2% -$12K 0.02% 229
2019
Q3 		$717K Sell
11,315
-3,704
-25% -$242K 0.03% 225
2019
Q2 		$1.01M Sell
15,019
-18,046
-55% -$1.19M 0.04% 199
2019
Q1 		$2.15M Buy
33,065
+30,525
+1,202% +$2.03M 0.08% 136
2018
Q4 		$159K Sell
2,540
-72,732
-97% -$5.08M 0.47% 57
2018
Q3 		$5.81M Sell
75,272
-46,792
-38% -$3.53M 0.26% 73
2018
Q2 		$8.65M Sell
122,064
-15,430
-11% -$1.09M 0.37% 64
2018
Q1 		$10.4M Buy
137,494
+23,662
+21% +$1.88M 0.43% 62
2017
Q4 		$8.15M Sell
113,832
-1,776
-2% -$135K 0.33% 74
2017
Q3 		$9.37M Buy
115,608
+10,969
+10% +$839K 0.4% 65
2017
Q2 		$7.41M Buy
104,639
+31,018
+42% +$2.06M 0.33% 71
2017
Q1 		$5M Sell
73,621
-91,434
-55% -$6.43M 0.23% 87
2016
Q4 		$11.8M Sell
165,055
-36,462
-18% -$2.71M 0.56% 56
2016
Q3 		$15.9M Sell
201,517
-35,467
-15% -$2.88M 0.78% 46
2016
Q2 		$19.8M Buy
236,984
+2,777
+1% +$246K 0.99% 32
2016
Q1 		$21.5M Buy
234,207
+11,932
+5% +$1.08M 1.12% 26
2015
Q4 		$22.5M Buy
222,275
+29,278
+15% +$3.05M 1.16% 26
2015
Q3 		$18.9M Buy
192,997
+11,127
+6% +$1.24M 1.03% 31
2015
Q2 		$21.3M Buy
181,870
+13,691
+8% +$1.5M 1.06% 31
2015
Q1 		$16.5M Buy
168,179
+164,635
+4,645% +$16.7M 0.82% 41
2014
Q4 		$334K Buy
+3,544
New +$367K 0.02% 244

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

HM Payson & Co's GILD Position: Q2 2026 in Review

HM Payson & Co reduced its Gilead Sciences (GILD) stake by 5.1% in Q2 2026, selling an estimated $49.5K and leaving 7,060 shares worth $892K. The position accounts for 0.01% of the portfolio, ranked #238.

HM Payson & Co first reported a position in GILD in Q4 2014 and has held it in 47 quarters since. The position peaked at $22.5M in Q4 2015. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • HM Payson & Co held 7,060 shares of Gilead Sciences worth $892K as of Q2 2026.
  • HM Payson & Co sold 376 Gilead Sciences shares in Q2 2026, an estimated $49.5K.
  • Gilead Sciences made up 0.01% of HM Payson & Co's portfolio in Q2 2026, its #238 holding.
  • HM Payson & Co first reported a position in Gilead Sciences in Q4 2014 and has held it in 47 quarters since.
  • HM Payson & Co's Gilead Sciences position peaked at $22.5M in Q4 2015.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.